{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T02:39:46Z","timestamp":1794883186550,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A2C2007430"],"award-info":[{"award-number":["2021R1A2C2007430"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Pancreatic ductal adenocarcinoma (PDAC) is characterized by poor prognosis and resistance to conventional therapies, necessitating novel treatments. The high proliferative rate and protein synthesis in PDAC induce endoplasmic reticulum (ER) stress, with Glucose-Regulated Protein 78 (GRP78), a key regulator of ER stress and the Unfolded Protein Response (UPR), playing a pivotal role in PDAC progression. Despite its relevance, GRP78-targeted therapies remain unexplored in PDAC. BOLD-100, a novel GRP78 inhibitor, presents a potential therapeutic approach by disrupting GRP78 transcription, though its effects on PDAC have yet to be fully elucidated. Here, we found that BOLD-100 induces PDAC cell death through the UPR pathway activation, leading to CHOP-dependent apoptosis. BOLD-100 generates reactive oxygen species (ROS), inducing R-loop formation that triggers a DNA damage response via the ATR\/Chk1 axis. BOLD-100 synergizes with AZD6738, an ATR inhibitor, to enhance anti-tumor efficacy compared to either agent alone in both in vitro and in vivo models. These findings suggest that BOLD-100, especially in combination with an ATR inhibitor, represents a promising therapeutic option for patients with PDAC.\n<\/jats:p>","DOI":"10.1186\/s12964-025-02242-8","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T09:57:10Z","timestamp":1749808630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Therapeutic potential of BOLD-100, a GRP78 inhibitor, enhanced by ATR inhibition in pancreatic ductal adenocarcinoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Su In","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ah-Rong","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Seok","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Hee","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoojin","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sea Young","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeesun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Youn","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"2242_CR1","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV, et al. Pancreatic cancer. Nat Rev Dis Primers. 2016;2:16022.","journal-title":"Nat Rev Dis Primers"},{"key":"2242_CR2","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.3748\/wjg.v21.i11.3157","volume":"21","author":"D Ansari","year":"2015","unstructured":"Ansari D, Gustafsson A, Andersson R. Update on the management of pancreatic cancer: surgery is not enough. World J Gastroenterol. 2015;21:3157\u201365.","journal-title":"World J Gastroenterol"},{"key":"2242_CR3","doi-asserted-by":"crossref","unstructured":"Adamska A, Domenichini A, Falasca M. Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies. Int J Mol Sci. 2017;18(7):1338.","DOI":"10.3390\/ijms18071338"},{"key":"2242_CR4","doi-asserted-by":"crossref","unstructured":"Botrus G, Miller RM, Uson Junior PLS, Kannan G, Han H, Von Hoff DD. Increasing Stress to Induce Apoptosis in Pancreatic Cancer via the Unfolded Protein Response (UPR). Int J Mol Sci. 2022;24(1):249.","DOI":"10.3390\/ijms24010577"},{"key":"2242_CR5","doi-asserted-by":"publisher","first-page":"32154","DOI":"10.18632\/oncotarget.5168","volume":"6","author":"B Kong","year":"2015","unstructured":"Kong B, Cheng T, Wu W, Regel I, Raulefs S, Friess H, et al. Hypoxia-induced endoplasmic reticulum stress characterizes a necrotic phenotype of pancreatic cancer. Oncotarget. 2015;6(31):32154\u201360.","journal-title":"Oncotarget"},{"key":"2242_CR6","doi-asserted-by":"crossref","unstructured":"Robinson CM, Talty A, Logue SE, Mnich K, Gorman AM, Samali A. An Emerging Role for the Unfolded Protein Response in Pancreatic Cancer. Cancers (Basel). 2021;13(2):273.","DOI":"10.3390\/cancers13020261"},{"key":"2242_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3389\/fmed.2020.00351","volume":"7","author":"G Lu","year":"2020","unstructured":"Lu G, Luo H, Zhu X. Targeting the GRP78 Pathway for Cancer Therapy. Front Med (Lausanne). 2020;7:351.","journal-title":"Front Med (Lausanne)"},{"key":"2242_CR8","doi-asserted-by":"crossref","unstructured":"Dauer P, Sharma NS, Gupta VK, Durden B, Hadad R, Banerjee S, et al. ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining \u201cstemness\u201d. Cell Death Dis. 2019;10:132.","DOI":"10.1038\/s41419-019-1408-5"},{"key":"2242_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.101020","volume":"55","author":"V Yamamoto","year":"2024","unstructured":"Yamamoto V, Ha DP, Liu Z, Huang M, Samanta S, Neamati N, et al. GRP78 inhibitor YUM70 upregulates 4E-BP1 and suppresses c-MYC expression and viability of oncogenic c-MYC tumors. Neoplasia. 2024;55:101020.","journal-title":"Neoplasia"},{"key":"2242_CR10","doi-asserted-by":"crossref","unstructured":"Akinyemi AO, Simpson KE, Oyelere SF, Nur M, Ngule CM, Owoyemi BCD, et al. Unveiling the dark side of glucose-regulated protein 78 (GRP78) in cancers and other human pathology: a systematic review. Heliyon. 2023;9(9):e20606.","DOI":"10.1186\/s10020-023-00706-6"},{"key":"2242_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/ijms24010577","volume":"24","author":"G Botrus","year":"2023","unstructured":"Botrus G, Miller RM, Uson Junior PLS, Kannan G, Han H, Von Hoff DD. Increasing Stress to Induce Apoptosis in Pancreatic Cancer via the Unfolded Protein Response (UPR).\u00a0Int J Mol Sci. 2023;24(1):577.","journal-title":"International Journal of Molecular Sciences"},{"key":"2242_CR12","doi-asserted-by":"crossref","unstructured":"Arab HH, Khames A, Alsufyani SE, El-Sheikh AAK, Gad AM. Targeting the Endoplasmic Reticulum Stress-Linked PERK\/GRP78\/CHOP Pathway with Magnesium Sulfate Attenuates Chronic-Restraint-Stress-Induced Depression-like Neuropathology in Rats. Pharmaceuticals (Basel). 2023;16(2):273.","DOI":"10.3390\/ph16020300"},{"key":"2242_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2174\/1566524016666160523143937","volume":"16","author":"W Rozpedek","year":"2016","unstructured":"Rozpedek W, Pytel D, Mucha B, Leszczynska H, Diehl JA, Majsterek I. The Role of the PERK\/eIF2\u03b1\/ATF4\/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum Stress. Curr Mol Med. 2016;16(6):533\u201344.","journal-title":"Curr Mol Med"},{"key":"2242_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1158\/0008-5472.CAN-07-2950","volume":"68","author":"D Dong","year":"2008","unstructured":"Dong D, Ni M, Li J, Xiong S, Ye W, Virrey JJ, et al. Critical role of the stress chaperone GRP78\/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Res. 2008;68(2):498\u2013505.","journal-title":"Cancer Res"},{"key":"2242_CR15","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1158\/0008-5472.CAN-10-3151","volume":"71","author":"D Dong","year":"2011","unstructured":"Dong D, Stapleton C, Luo B, Xiong S, Ye W, Zhang Y, et al. A critical role for GRP78\/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis. Cancer Res. 2011;71(8):2848\u201357.","journal-title":"Cancer Res"},{"key":"2242_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrc3701","volume":"14","author":"AS Lee","year":"2014","unstructured":"Lee AS. Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential. Nat Rev Cancer. 2014;14(4):263\u201376.","journal-title":"Nat Rev Cancer"},{"key":"2242_CR17","first-page":"13","volume":"2012","author":"Z Li","year":"1826","unstructured":"Li Z, Li Z. Glucose regulated protein 78: a critical link between tumor microenvironment and cancer hallmarks. Biochim Biophys Acta. 2012;1826(1):13\u201322.","journal-title":"Biochim Biophys Acta"},{"key":"2242_CR18","unstructured":"Niu Z, Wang M, Zhou L, Yao L, Liao Q, Zhao Y. Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancer. Sci Rep. 2017;7:7291."},{"key":"2242_CR19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1089\/ars.2014.5851","volume":"21","author":"SS Cao","year":"2014","unstructured":"Cao SS, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid Redox Signal. 2014;21(3):396\u2013413.","journal-title":"Antioxid Redox Signal"},{"key":"2242_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.138","volume":"7","author":"H Wang","year":"2016","unstructured":"Wang H, Zhang T, Sun W, Wang Z, Zuo D, Zhou Z, et al. Erianin induces G2\/M-phase arrest, apoptosis, and autophagy via the ROS\/JNK signaling pathway in human osteosarcoma cells in vitro and in vivo. Cell Death Dis. 2016;7(6):e2247.","journal-title":"Cell Death Dis"},{"key":"2242_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/sj.cdd.4402233","volume":"15","author":"Y Chen","year":"2008","unstructured":"Chen Y, McMillan-Ward E, Kong J, Israels SJ, Gibson SB. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ. 2008;15(1):171\u201382.","journal-title":"Cell Death Differ"},{"key":"2242_CR22","first-page":"1427","volume":"42","author":"JR Heo","year":"2018","unstructured":"Heo JR, Kim SM, Hwang KA, Kang JH, Choi KC. Resveratrol induced reactive oxygen species and endoplasmic reticulum stress\u2011mediated apoptosis, and cell cycle arrest in the A375SM malignant melanoma cell line. Int J Mol Med. 2018;42(3):1427\u201335.","journal-title":"Int J Mol Med"},{"key":"2242_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2018.101084","volume":"25","author":"US Srinivas","year":"2019","unstructured":"Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD. ROS and the DNA damage response in cancer. Redox Biol. 2019;25:101084.","journal-title":"Redox Biol"},{"key":"2242_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","volume":"16","author":"PG Pili\u00e9","year":"2019","unstructured":"Pili\u00e9 PG, Tang C, Mills GB, Yap TA. State-of-the-art strategies for targeting the DNA damage response in cancer. Nat Rev Clin Oncol. 2019;16(2):81\u2013104.","journal-title":"Nat Rev Clin Oncol"},{"key":"2242_CR25","doi-asserted-by":"crossref","unstructured":"Bakewell S, Conde I, Fallah Y, McCoy M, Jin L, Shajahan-Haq AN. Inhibition of DNA Repair Pathways and Induction of ROS Are Potential Mechanisms of Action of the Small Molecule Inhibitor BOLD-100 in Breast Cancer. Cancers (Basel). 2020;12(9):2538.","DOI":"10.3390\/cancers12092647"},{"key":"2242_CR26","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1158\/1535-7163.MCT-15-0774","volume":"15","author":"JB Gifford","year":"2016","unstructured":"Gifford JB, Huang W, Zeleniak AE, Hindoyan A, Wu H, Donahue TR, et al. Expression of GRP78, Master Regulator of the Unfolded Protein Response, Increases Chemoresistance in Pancreatic Ductal Adenocarcinoma. Mol Cancer Ther. 2016;15(5):1043\u201352.","journal-title":"Mol Cancer Ther"},{"key":"2242_CR27","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1016\/j.ejca.2013.05.018","volume":"49","author":"P Heffeter","year":"2013","unstructured":"Heffeter P, Atil B, Kryeziu K, Groza D, Koellensperger G, Korner W, et al. The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo. Eur J Cancer. 2013;49(15):3366\u201375.","journal-title":"Eur J Cancer"},{"key":"2242_CR28","doi-asserted-by":"publisher","first-page":"29698","DOI":"10.18632\/oncotarget.25679","volume":"9","author":"SJ Bakewell","year":"2018","unstructured":"Bakewell SJ, Rangel DF, Ha DP, Sethuraman J, Crouse R, Hadley E, et al. Suppression of stress induction of the 78-kilodalton glucose regulated protein (GRP78) in cancer by IT-139, an anti-tumor ruthenium small molecule inhibitor. Oncotarget. 2018;9(51):29698\u2013714.","journal-title":"Oncotarget"},{"key":"2242_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S1534-5807(02)00203-4","volume":"3","author":"J Shen","year":"2002","unstructured":"Shen J, Chen X, Hendershot L, Prywes R. ER Stress Regulation of ATF6 Localization by Dissociation of BiP\/GRP78 Binding and Unmasking of Golgi Localization Signals. Developmental Cell. 2002;3(1):99\u2013111.","journal-title":"Dev Cell"},{"key":"2242_CR30","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1089\/ars.2009.2485","volume":"11","author":"M Wang","year":"2009","unstructured":"Wang M, Wey S, Zhang Y, Ye R, Lee AS. Role of the unfolded protein response regulator GRP78\/BiP in development, cancer, and neurological disorders. Antioxid Redox Signal. 2009;11(9):2307\u201316.","journal-title":"Antioxid Redox Signal"},{"key":"2242_CR31","unstructured":"Chen MZ, Moily NS, Bridgford JL, Wood RJ, Radwan M, Smith TA, et al. A thiol probe for measuring unfolded protein load and proteostasis in cells. Nat Commun. 2020;11:6194."},{"key":"2242_CR32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.redox.2014.12.003","volume":"4","author":"L Poillet-Perez","year":"2015","unstructured":"Poillet-Perez L, Despouy G, Delage-Mourroux R, Boyer-Guittaut M. Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy. Redox Biol. 2015;4:184\u201392.","journal-title":"Redox Biol"},{"key":"2242_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/ijms17030327","volume":"17","author":"HM Zeeshan","year":"2016","unstructured":"Zeeshan HM, Lee GH, Kim HR, Chae HJ. Endoplasmic Reticulum Stress and Associated ROS. Int J Mol Sci. 2016;17(3):327.","journal-title":"Int J Mol Sci"},{"key":"2242_CR34","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000488433","volume":"46","author":"CL Lin","year":"2018","unstructured":"Lin CL, Lee CH, Chen CM, Cheng CW, Chen PN, Ying TH, et al. Protodioscin Induces Apoptosis Through ROS-Mediated Endoplasmic Reticulum Stress via the JNK\/p38 Activation Pathways in Human Cervical Cancer Cells. Cell Physiol Biochem. 2018;46(1):322\u201334.","journal-title":"Cell Physiol Biochem"},{"key":"2242_CR35","doi-asserted-by":"crossref","unstructured":"Wang YY, Lee KT, Lim MC, Choi JH. TRPV1 Antagonist DWP05195 Induces ER Stress-Dependent Apoptosis through the ROS-p38-CHOP Pathway in Human Ovarian Cancer Cells. Cancers (Basel). 2020;12(6):1480.","DOI":"10.3390\/cancers12061702"},{"key":"2242_CR36","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.7150\/ijbs.63963","volume":"17","author":"X Xie","year":"2021","unstructured":"Xie X, Zhang Y, Wang Z, Wang S, Jiang X, Cui H, et al. ATM at the crossroads of reactive oxygen species and autophagy. Int J Biol Sci. 2021;17(12):3080\u201390.","journal-title":"Int J Biol Sci"},{"key":"2242_CR37","doi-asserted-by":"publisher","first-page":"7534","DOI":"10.1158\/0008-5472.CAN-14-2650","volume":"74","author":"M Kawasumi","year":"2014","unstructured":"Kawasumi M, Bradner JE, Tolliday N, Thibodeau R, Sloan H, Brummond KM, et al. Identification of ATR-Chk1 pathway inhibitors that selectively target p53-deficient cells without directly suppressing ATR catalytic activity. Cancer Res. 2014;74(24):7534\u201345.","journal-title":"Cancer Res"},{"key":"2242_CR38","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrm.2017.67","volume":"18","author":"JC Saldivar","year":"2017","unstructured":"Saldivar JC, Cortez D, Cimprich KA. The essential kinase ATR: ensuring faithful duplication of a challenging genome. Nat Rev Mol Cell Biol. 2017;18(10):622\u201336.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2242_CR39","doi-asserted-by":"crossref","unstructured":"Flocke LS, Trondl R, Jakupec MA, Keppler BK. Molecular mode of action of NKP-1339 - a clinically investigated ruthenium-based drug - involves ER- and ROS-related effects in colon carcinoma cell lines. Invest New Drugs. 2016;34(3):261\u20138.","DOI":"10.1007\/s10637-016-0337-8"},{"key":"2242_CR40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10637-016-0337-8","volume":"34","author":"LS Flocke","year":"2016","unstructured":"Ranzato E, Bonsignore G, Martinotti S. ER Stress Response and Induction of Apoptosis in Malignant Pleural Mesothelioma: The Achilles Heel Targeted by the Anticancer Ruthenium Drug BOLD-100. Cancers (Basel). 2022;14(17):4283.","journal-title":"Invest New Drugs"},{"key":"2242_CR41","doi-asserted-by":"crossref","unstructured":"Andrs M, Stoy H, Boleslavska B, Chappidi N, Kanagaraj R, Nascakova Z, et al. Excessive reactive oxygen species induce transcription-dependent replication stress. Nucleic Acids Res. 2023;51(15):7686\u2013704.","DOI":"10.1038\/s41467-023-37341-y"},{"key":"2242_CR42","unstructured":"Teng Y, Yadav T, Duan M, Tan J, Xiang Y, Gao B, et al. ROS-induced R loops trigger a transcription-coupled but BRCA1\/2-independent homologous recombination pathway through CSB. Nat Commun. 2021;12:411."},{"key":"2242_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2021.103199","volume":"107","author":"S Kemiha","year":"2021","unstructured":"Kemiha S, Poli J, Lin YL, Lengronne A, Pasero P. Toxic R-loops: Cause or consequence of replication stress? DNA Repair (Amst). 2021;107:103199.","journal-title":"DNA Repair (Amst)"},{"key":"2242_CR44","doi-asserted-by":"publisher","first-page":"11584","DOI":"10.1093\/nar\/gkad858","volume":"51","author":"TS Ma","year":"2023","unstructured":"Ma TS, Worth KR, Maher C, Ng N, Begh\u00e8 C, Gromak N, et al. Hypoxia-induced transcriptional stress is mediated by ROS-induced R-loops. Nucleic Acids Res. 2023;51(21):11584\u201399.","journal-title":"Nucleic Acids Res"},{"key":"2242_CR45","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.molcel.2013.10.006","volume":"52","author":"M Castellano-Pozo","year":"2013","unstructured":"Castellano-Pozo M, Santos-Pereira JM, Rond\u00f3n AG, Barroso S, And\u00fajar E, P\u00e9rez-Alegre M, et al. R loops are linked to histone H3 S10 phosphorylation and chromatin condensation. Mol Cell. 2013;52(4):583\u201390.","journal-title":"Mol Cell"},{"key":"2242_CR46","unstructured":"Niehrs C, Luke B. Regulatory R-loops as facilitators of gene expression and genome stability. Nat Rev Mol Cell Biol. 2023;24:84\u2013103."},{"key":"2242_CR47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.molcel.2016.05.032","volume":"63","author":"LA Sanz","year":"2016","unstructured":"Sanz LA, Hartono SR, Lim YW, Steyaert S, Rajpurkar A, Ginno PA, et al. Prevalent, Dynamic, and Conserved R-Loop Structures Associate with Specific Epigenomic Signatures in Mammals. Mol Cell. 2016;63(1):167\u201378.","journal-title":"Mol Cell"},{"key":"2242_CR48","doi-asserted-by":"crossref","unstructured":"Gold S, Shilatifard A. Epigenetic therapies targeting histone lysine methylation: complex mechanisms and clinical challenges.\u00a0J Clin Invest. 2024;134(20):e174349.","DOI":"10.1172\/JCI183391"},{"key":"2242_CR49","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1021\/acschembio.2c00062","volume":"17","author":"MY Wang","year":"2022","unstructured":"Wang MY, Liow P, Guzman MIT, Qi J. Exploring Methods of Targeting Histone Methyltransferases and Their Applications in Cancer Therapeutics. ACS Chem Biol. 2022;17(4):744\u201355.","journal-title":"ACS Chem Biol"},{"key":"2242_CR50","doi-asserted-by":"crossref","unstructured":"De Marco K, Sanese P, Simone C, Grossi V. Histone and DNA methylation as epigenetic regulators of DNA damage repair in gastric cancer and emerging therapeutic opportunities. Cancers (Basel). 2023;15(20):4937.","DOI":"10.3390\/cancers15204976"},{"key":"2242_CR51","doi-asserted-by":"crossref","unstructured":"Griffin D, Carson R, Moss D, Sessler T, Lavin D, Tiwari VK, et al. Ruthenium drug BOLD-100 regulates BRAF^MT colorectal cancer cell apoptosis through AhR\/ROS\/ATR signaling axis modulation. Mol Cancer Res. 2024;22(2):93\u2013104.","DOI":"10.1158\/1541-7786.27951016"},{"key":"2242_CR52","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.1002\/anie.202015962","volume":"60","author":"B Neuditschko","year":"2021","unstructured":"Neuditschko B, Legin AA, Baier D, Schintlmeister A, Reipert S, Wagner M, et al. Interaction with Ribosomal Proteins Accompanies Stress Induction of the Anticancer Metallodrug BOLD-100\/KP1339 in the Endoplasmic Reticulum. Angew Chem Int Ed Engl. 2021;60(10):5063\u20138.","journal-title":"Angew Chem Int Ed Engl"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02242-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02242-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02242-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T09:57:16Z","timestamp":1749808636000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02242-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2242"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02242-8","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Oh DY is a consultant or advisory board member of AstraZeneca, Novartis, Genentech\/Roche, Merck Serono, Bayer, Taiho, ASLAN, Halozyme, Zymeworks, BMS\/Celgene, BeiGene, Basilea, Turning Point, Yuhan, Arcus Biosciences, IQVIA, MSD, LG Chem, Astellas, Abbvie, J-Pharma, Mirati Therapeutics, Eutilex, Moderna, Idience, Alligator Bioscience AB, Hana pharm. Research grant from AstraZeneca, Novartis, Array, Eli Lilly, Servier, BeiGene, MSD, and Handok.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"281"}}